Fig. 5
A, B Mice with DU4475 tumors were initially administered 0.8 mg or 0.6 mg iMN041 SC in FS-19 qod or PBS (n =10 per group). Mean tumor volume +/- SD at study initiation was 57 mm3 +/- 7.4. A Graph of DU4475 growth in iMN041 treated versus vehicle control animals. B Survival proportions in DU4475 implants: 0.8 mg treated mice vs. control mice 21 vs. 18 days (p = 0.019), 0.6 mg treated mice 25 vs. 18 days (p = 0.0032)